Des Jarlais
Don C. Des Jarlais, PhD
CDUHR - Associate Director, Infectious Disease Epidemiology and Theory Core
NYU School of Global Public Health - Professor
PhD, Social Psychology, University of Michigan, Ann Arbor
BA, Behavioral Science, Rice University
Research Interests
Injecting drug use, Epidemiology, HIV, HCV, Research synthesis
For over 30 years Don Des Jarlais has been conducting HIV/AIDS research among persons who inject drugs (PWID). He is PI of the “Risk Factors” study (R01DA003574), which was instrumental in tracking the HIV/AIDS epidemic in New York City. This study has been funded by the National Institute on Drug Abuse since 1983 and is the longest continuously funded study on HIV/AIDS in persons who use drugs. He has conducted HIV/AIDS research nationally (Seattle, CDC CIDUS studies, national syringe exchange survey) and internationally (in over 20 different countries). He has served as a consultant on these issues to the World Health Organization, the National Institutes of Health and the U.S. Centers for Disease Control and Prevention.
Principal Investigator, Combined Prevention to Reduce Initiation Into Injecting Drug Use. Active
Principal Investigator, DRIVE (Drug Use and Blood-Borne Infections in Vietnam): Combined Prevention and Care to End the HIV Epidemic Among People Who Inject Drugs in Haiphong, Vietnam. Active
Principal Investigator, Risk Factors for AIDS among Drug Users: Getting Close to Zero. Active
Principal Investigator, Barriers to Reason: Laws Impacting HIV Prevention Efforts among IDUs in the United States. Completed
Principal Investigator, Combined HIV Prevention for PWID and Future Collaborative Research in Vietnam. Completed
Principal Investigator, Evaluating ART for All HIV Seropositives: Can It Work with the Hardest Cases?. Completed
Principal Investigator, Expanded Syringe Access Program: NY Evaluation (ESAP). Completed
Principal Investigator, HIV Infection in Ethnic Minority IDUs: An International Systematic Review. Completed
Principal Investigator, HIV Transmission among Injecting and Non-Injecting Drug Users in Tallinn, Estonia. Completed
Principal Investigator, Multiple HIV Prevention Packages for IDUs in Estonia. Completed
Principal Investigator, National Study of Syringe Exchange Programs. Completed
Principal Investigator, WHO Survey Coordinating Center, Drug Injecting Study – Phase 2. Completed


Des Jarlais DC, Feelemyer J, LaKosky P, Szymanowski K, Arasteh K (2020).
Expansion of syringe service programs in the United States, 2015-2018
American Journal of Public Health, 110 (4), 517-519. doi: 10.2105/AJPH.2019.305515.

Linton SL, Cooper HLF, Chen YT, Khan MA, Wolfe ME, Ross Z, Des Jarlais DC, Friedman SR, Tempalski B, Broz D, Semaan S, Wejnert C, Paz-Bailey G (2020).
Mortgage discrimination and racial/ethnic concentration are associated with same-race/ethnicity partnering among people who inject drugs in 19 US cities
Journal of Urban Health, 97 (1), 88-104. doi: 10.1007/s11524-019-00405-w.

Pavlopoulou ID, Dikalioti SK, Gountas I, Sypsa V, Malliori M, Pantavou K, Des Jarlais D, Nikolopoulos GK, Hatzakis A (2020).
High-risk behaviors and their association with awareness of HIV status among participants of a large-scale prevention intervention in Athens, Greece
BMC Public Health, 20 (1), 105. doi: 10.1186/s12889-020-8178-y. PMCID: PMC6986033.

Uuskula A, Des Jarlais D, Vorobjov S (2019).
The fentanyl epidemic in Estonia: Opportunities for a comprehensive public health response
Lancet Psychiatry, 6 (12), 985. doi: 10.1016/S2215-0366(19)30436-5.

Arasteh K, Des Jarlais DC, McKnight C, Feelemyer J (2019).
Injection and heterosexual risk behaviors for HIV infection among non-gay identifying men who have sex with men and women
AIDS and Behavior, 23 (12), 3315-3323. doi: 10.1007/s10461-019-02551-3.


Des Jarlais DC, Duong HT (2018).
Ending HIV epidemics among people who inject drugs in LMICs
Lancet, 392 (10149), 714-719. doi: 10.1016/S0140-6736(18)31721-5.

Dr. Des Jarlais' ResearchGate Profile
Selected Press